» Articles » PMID: 20164420

Antiviral Response Dictated by Choreographed Cascade of Transcription Factors

Overview
Journal J Immunol
Date 2010 Feb 19
PMID 20164420
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

The dendritic cell (DC) is a master regulator of immune responses. Pathogenic viruses subvert normal immune function in DCs through the expression of immune antagonists. Understanding how these antagonists interact with the host immune system requires knowledge of the underlying genetic regulatory network that operates during an uninhibited antiviral response. To isolate and identify this network, we studied DCs infected with Newcastle disease virus, which is able to stimulate innate immunity and DC maturation through activation of RIG-I signaling, but lacks the ability to evade the human IFN response. To analyze this experimental model, we developed a new approach integrating genome-wide expression kinetics and time-dependent promoter analysis. We found that the genetic program underlying the antiviral cell-state transition during the first 18 h postinfection could be explained by a single convergent regulatory network. Gene expression changes were driven by a stepwise multifactor cascading control mechanism, where the specific transcription factors controlling expression changed over time. Within this network, most individual genes were regulated by multiple factors, indicating robustness against virus-encoded immune evasion genes. In addition to effectively recapitulating current biological knowledge, we predicted, and validated experimentally, antiviral roles for several novel transcription factors. More generally, our results show how a genetic program can be temporally controlled through a single regulatory network to achieve the large-scale genetic reprogramming characteristic of cell-state transitions.

Citing Articles

Quantitative characterization of immune cells by measuring cellular signal transduction pathway activity.

Bouwman W, Verhaegh W, van Doorn A, Raymakers R, van der Poll T, van de Stolpe A Sci Rep. 2024; 14(1):24487.

PMID: 39424625 PMC: 11489675. DOI: 10.1038/s41598-024-75666-w.


Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution.

Schirrmacher V, Van Gool S, Stuecker W Biomedicines. 2024; 12(4).

PMID: 38672110 PMC: 11048616. DOI: 10.3390/biomedicines12040754.


Counteracting Immunosuppression in the Tumor Microenvironment by Oncolytic Newcastle Disease Virus and Cellular Immunotherapy.

Schirrmacher V, Van Gool S, Stuecker W Int J Mol Sci. 2022; 23(21).

PMID: 36361831 PMC: 9655431. DOI: 10.3390/ijms232113050.


Molecular Mechanisms of Anti-Neoplastic and Immune Stimulatory Properties of Oncolytic Newcastle Disease Virus.

Schirrmacher V Biomedicines. 2022; 10(3).

PMID: 35327364 PMC: 8945571. DOI: 10.3390/biomedicines10030562.


Unraveling the Effects of a Talimogene Laherparepvec (T-VEC)-Induced Tumor Oncolysate on Myeloid Dendritic Cells.

Tijtgat J, De Munck J, Dufait I, Schwarze J, Van Riet I, Franceschini L Front Immunol. 2021; 12:733506.

PMID: 34777344 PMC: 8581672. DOI: 10.3389/fimmu.2021.733506.


References
1.
Petrocca F, Lieberman J . Micromanagers of immune cell fate and function. Adv Immunol. 2009; 102:227-44. DOI: 10.1016/S0065-2776(09)01204-8. View

2.
Gilchrist M, Thorsson V, Li B, Rust A, Korb M, Roach J . Systems biology approaches identify ATF3 as a negative regulator of Toll-like receptor 4. Nature. 2006; 441(7090):173-8. DOI: 10.1038/nature04768. View

3.
Tan K, Tegner J, Ravasi T . Integrated approaches to uncovering transcription regulatory networks in mammalian cells. Genomics. 2008; 91(3):219-31. DOI: 10.1016/j.ygeno.2007.11.005. View

4.
Falcon S, Gentleman R . Using GOstats to test gene lists for GO term association. Bioinformatics. 2006; 23(2):257-8. DOI: 10.1093/bioinformatics/btl567. View

5.
Pruitt K, Tatusova T, Maglott D . NCBI Reference Sequence (RefSeq): a curated non-redundant sequence database of genomes, transcripts and proteins. Nucleic Acids Res. 2004; 33(Database issue):D501-4. PMC: 539979. DOI: 10.1093/nar/gki025. View